These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22191525)

  • 21. Antibiotics that affect the ribosome.
    Lambert T
    Rev Sci Tech; 2012 Apr; 31(1):57-64. PubMed ID: 22849268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual effects of MLS antibiotics: transcriptional modulation and interactions on the ribosome.
    Tsui WH; Yim G; Wang HH; McClure JE; Surette MG; Davies J
    Chem Biol; 2004 Sep; 11(9):1307-16. PubMed ID: 15380191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence polarization method to characterize macrolide-ribosome interactions.
    Yan K; Hunt E; Berge J; May E; Copeland RA; Gontarek RR
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3367-72. PubMed ID: 16048949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The macrolide-bacterium interaction and its biological basis.
    Goldman RC; Scaglione F
    Curr Drug Targets Infect Disord; 2004 Sep; 4(3):241-60. PubMed ID: 15379734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antibiotics on large ribosomal subunit assembly reveals possible function of 5 S rRNA.
    Khaitovich P; Mankin AS
    J Mol Biol; 1999 Sep; 291(5):1025-34. PubMed ID: 10518940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular determinants of microbial resistance to thiopeptide antibiotics.
    Baumann S; Schoof S; Bolten M; Haering C; Takagi M; Shin-ya K; Arndt HD
    J Am Chem Soc; 2010 May; 132(20):6973-81. PubMed ID: 20441189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribosomal tunnel and translation regulation.
    Bogdanov AA; Sumbatyan NV; Shishkina AV; Karpenko VV; Korshunova GA
    Biochemistry (Mosc); 2010 Dec; 75(13):1501-16. PubMed ID: 21417991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The general mode of translation inhibition by macrolide antibiotics.
    Kannan K; Kanabar P; Schryer D; Florin T; Oh E; Bahroos N; Tenson T; Weissman JS; Mankin AS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15958-63. PubMed ID: 25349425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribosomal antibiotics: structural basis for resistance, synergism and selectivity.
    Auerbach T; Bashan A; Yonath A
    Trends Biotechnol; 2004 Nov; 22(11):570-6. PubMed ID: 15491801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin.
    Lovmar M; Vimberg V; Lukk E; Nilsson K; Tenson T; Ehrenberg M
    Biochimie; 2009 Aug; 91(8):989-95. PubMed ID: 19463886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced Methods for Studying Structure and Interactions of Macrolide Antibiotics.
    Jednačak T; Mikulandra I; Novak P
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational analysis of ketolide, conformations of RU 004 in solution and bound to bacterial ribosomes.
    Bertho G; Gharbi-Benarous J; Delaforge M; Lang C; Parent A; Girault JP
    J Med Chem; 1998 Aug; 41(18):3373-86. PubMed ID: 9719590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ribosomal antibiotics].
    Man'kin AS
    Mol Biol (Mosk); 2001; 35(4):597-609. PubMed ID: 11524946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugates of amino acids and peptides with 5-o-mycaminosyltylonolide and their interaction with the ribosomal exit tunnel.
    Shishkina A; Makarov G; Tereshchenkov A; Korshunova G; Sumbatyan N; Golovin A; Svetlov M; Bogdanov A
    Bioconjug Chem; 2013 Nov; 24(11):1861-9. PubMed ID: 24090034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanism of drug-dependent ribosome stalling.
    Vazquez-Laslop N; Thum C; Mankin AS
    Mol Cell; 2008 Apr; 30(2):190-202. PubMed ID: 18439898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide-mediated macrolide resistance reveals possible specific interactions in the nascent peptide exit tunnel.
    Vimberg V; Xiong L; Bailey M; Tenson T; Mankin A
    Mol Microbiol; 2004 Oct; 54(2):376-85. PubMed ID: 15469510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward the rational design of macrolide antibiotics to combat resistance.
    Pavlova A; Parks JM; Oyelere AK; Gumbart JC
    Chem Biol Drug Des; 2017 Nov; 90(5):641-652. PubMed ID: 28419786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A crevice adjoining the ribosome tunnel: hints for cotranslational folding.
    Amit M; Berisio R; Baram D; Harms J; Bashan A; Yonath A
    FEBS Lett; 2005 Jun; 579(15):3207-13. PubMed ID: 15943964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The macrolide binding site on the bacterial ribosome.
    Poehlsgaard J; Douthwaite S
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):67-78. PubMed ID: 12462154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribosome-binding and anti-microbial studies of the mycinamicins, 16-membered macrolide antibiotics from Micromonospora griseorubida.
    Breiner-Goldstein E; Eyal Z; Matzov D; Halfon Y; Cimicata G; Baum M; Rokney A; Ezernitchi AV; Lowell AN; Schmidt JJ; Rozenberg H; Zimmerman E; Bashan A; Valinsky L; Anzai Y; Sherman DH; Yonath A
    Nucleic Acids Res; 2021 Sep; 49(16):9560-9573. PubMed ID: 34417608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.